-
The Neuropathology Research team is part of the department of Pathology at Amsterdam UMC. The team consists of neuroscientists and neuropathologists working on research into neurodegenerative diseases, including Alzheimer’s disease, frontotemporal dementia and ALS, as well as other brain...
-
academic research, industry-based preclinical development, secondments, network-wide training and transferable-skills development. The PhD For this position, the recruiting organisation is the Istituto
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie
-
. Throughout the PhD project, you will have opportunities to further develop your scientific and transferable skills through the POLARIS doctoral training programme.
-
environment, combining academic research, industry-based preclinical development, secondments, network-wide training and transferable-skills development. The PhD Leukodystrophies are rare genetic disorders
-
provided by Prof Kleopa Kleopa and Dr Irene Sargiannidou from the Neuroscience Department. PhD project This doctoral project focuses on establishing isogenic iPSC-derived myelinating organoids as a
-
Deadline 5 Oct 2026 - 21:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not funded by a
-
) Application Deadline 5 Oct 2026 - 21:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not
-
environment, combining academic research, industry-based preclinical development, secondments, network-wide training and transferable-skills development. PhD project For this position, the recruiting
-
at the MITH research group, with the anticipated PhD defence at the Faculty of Medicine, Vrije Universiteit Brussel. You will contribute to the development of GPRC5B-targeting nanobodies from initial discovery